Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology.
Lim KHJ, Kamposioras K, Élez E, Haanen JBAG, Hardy C, Murali K, O'Connor M, Oing C, Punie K, de Azambuja E, Blay JY, Banerjee S; ESMO Resilience Task Force. Lim KHJ, et al. Among authors: oing c. ESMO Open. 2024 Oct;9(10):103634. doi: 10.1016/j.esmoop.2024.103634. Epub 2024 Sep 10. ESMO Open. 2024. PMID: 39461774 Free PMC article.
Social determinants of health inequalities in early phase clinical trials in Northern England.
Rae S, Shaya S, Taylor E, Hoben J, Oluwashegun D, Lowe H, Haris N, Bashir S, Oing C, Krebs MG, Thistlethwaite FC, Carter L, Cook N, Greystoke A, Graham DM, Plummer R. Rae S, et al. Among authors: oing c. Br J Cancer. 2024 Sep;131(4):685-691. doi: 10.1038/s41416-024-02765-w. Epub 2024 Jun 24. Br J Cancer. 2024. PMID: 38914804 Free PMC article.
Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis.
Seidel C, Schaefers C, Connolly EA, Weickhardt A, Grimison P, Wong V, De Giorgi U, Hentrich M, Zschäbitz S, Ochsenreither S, Vincenzi B, Oing C, Bokemeyer C, Engel N, Alsdorf W, Tran B. Seidel C, et al. Among authors: oing c. ESMO Open. 2024 May;9(5):103449. doi: 10.1016/j.esmoop.2024.103449. Epub 2024 May 13. ESMO Open. 2024. PMID: 38744098 Free PMC article.
Young oncologists' perspective on the role and future of the clinician-scientist in oncology.
Lim KHJ, Westphalen CB, Berghoff AS, Cardone C, Connolly EA, Güven DC, Kfoury M, Kocakavuk E, Mandó P, Mariamidze E, Matikas A, Moutafi M, Oing C, Pihlak R, Punie K, Sánchez-Bayona R, Sobczuk P, Starzer AM, Tečić Vuger A, Zhu H, Cruz-Ordinario MVB, Altuna SC, Canário R, Vuylsteke P, Banerjee S, de Azambuja E, Cervantes A, Lambertini M, Mateo J, Amaral T. Lim KHJ, et al. Among authors: oing c. ESMO Open. 2023 Oct;8(5):101625. doi: 10.1016/j.esmoop.2023.101625. Epub 2023 Aug 31. ESMO Open. 2023. PMID: 37659290 Free PMC article. No abstract available.
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis.
Messina C, Giunta EF, Signori A, Rebuzzi SE, Banna GL, Maniam A, Buti S, Cattrini C, Fornarini G, Bauckneht M, Greystoke A, Plummer R, Oing C, Rescigno P. Messina C, et al. Among authors: oing c. Eur Urol Oncol. 2024 Apr;7(2):179-188. doi: 10.1016/j.euo.2023.07.013. Epub 2023 Aug 12. Eur Urol Oncol. 2024. PMID: 37574390 Free article. Review.
87 results